Principal Financial Group Inc Protagonist Therapeutics, Inc Transaction History
Principal Financial Group Inc
- $172 Billion
- Q4 2024
A detailed history of Principal Financial Group Inc transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 337,809 shares of PTGX stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
337,809
Previous 320,832
5.29%
Holding current value
$12.7 Million
Previous $14.4 Billion
99.91%
% of portfolio
0.01%
Previous 0.87%
Shares
15 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58.9MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$223 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$216 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$207 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$125 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.85B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...